Exactech Marks 30 Year Anniversary with Introduction of New Clinical Solutions for Improved Patient Outcomes at AAOS 2015 Annual Meeting

Company Unveils Next Generation of ExactechGPS® and Cementless Option for Optetrak® Logic Knee, Launches Alteon® Brand of Hip Stems featuring Tapered Wedge Femoral Stem, Celebrates 10 Year Anniversary of Equinoxe® Shoulder System

AAOS 2015

GAINESVILLE, Fla.--()--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, marks its 30 year anniversary of developing and producing bone and joint restoration products including hip, knee, shoulder and spine surgery, by presenting a strong line-up of innovations at the company’s educational exhibit, booth #2025, at the American Academy of Orthopedic Surgeons (AAOS) 2015 Annual Meeting, March 24-27 in Las Vegas, NV.

EXACTECH KNEE

Offering advanced approaches in total knee arthroplasty, surgeons can have every confidence in the clinically recognized Exactech Knee system given its long-term clinical results1 and solutions for reproducible outcomes, case after case. Be among the first to see the most recent additions to the Exactech Knee product family:

  • The next generation of ExactechGPS® Guided Personalized Surgery merges sophisticated technology with innovative instrumentation for a real-time, patient-specific solution in total knee arthroplasty. Customized for surgeon preferences, ExactechGPS offers personalized workflow options for reproducibility and efficiency and is surgeon-controlled through a compact, stand-alone system that is designed to integrate into any surgical environment.
  • A new cementless fixation solution for total knee arthroplasty, Optetrak Logic® Porous femoral component strikes the optimal balance between material strength, pore size and porosity. In an ovine study*, the system’s proprietary material comprised of a unique 3-D structural lattice of irregular shaped particles demonstrated higher bone in-growth, greater shear strength and greater fixation than traditional porous-beaded coating.1

EXACTECH HIP

The Exactech Hip portfolio expands its scope of solutions to include:

  • The introduction of the Alteon® Tapered Wedge Femoral Stem. This next generation, single-taper, wedge-style femoral stem incorporates specific design features to achieve immediate axial and rotational mechanical stability between the medial and lateral cortices of the femoral canal.
  • The continued rollout of the Alteon Neck Preserving Femoral Stem which was developed for primary femoral solutions. Unlike traditional stems, this product is a conservative treatment option designed for maintaining the maximum amount of femoral bone.2
  • InteGrip® which is a three-dimensional, porous ingrowth material that was developed for acetabular cups in revision and complex primary procedures.

EXACTECH SHOULDER

The Equinoxe® Shoulder System celebrates 10 years of engineering solutions to solve clinical challenges and improve patient outcomes with the introduction of two additions to its wide range of glenoid options.

  • The Posterior Augment Cage Glenoid is designed to provide immediate fixation for anatomic TSA.
  • The Superior/Posterior Augment Baseplate is a new augment designed to correct for superior and posterior wear during challenging reverse procedures.

EXACTECH POWER EQUIPMENT

Implant removal solutions on display in Exactech’s technical exhibit include the AcuDriver® Automated Osteotome System, an air-driven impact handpiece with precision osteotomes in various sizes for use in revision surgeries.

EXACTECH SPACER

Exactech’s InterSpace® hip, knee and shoulder spacers are used in two-stage infected revision procedures and provide orthopaedic surgeons with the only preformed spacer on the market with a documented clinical history. Learn more about the unique and convenient way to treat this difficult problem and the data behind the only preformed spacer technology with 19 years of clinical experience.

EXACTECH BIOLOGICS

Exactech recognizes the growing importance of biologic solutions for orthopaedics and is proud to feature Optecure®, an engineered bone graft for reconstruction of the spine, pelvis and extremities. Its room temperature convenience facilitates rapid mixing with buffer solution or blood. Optecure and Optecure+ccc can be used with autologus bone and bone marrow.

Participate in Live Demos

Each day from 12:30 to 1:30pm, Gérard Giordano, MD and Bernard Stulberg, MD demonstrate the next generation of ExactechGPS®.

Clinicians may also gain first-hand experience with the AcuDriver® Automated Osteotome System and get an up-close look at our instrumentation in the surgical skills labs.

Enhance your AAOS Experience

At a time when so much is changing in our industry, surgeons might find it refreshing to know that Exactech is holding strong to its focus on surgeons’ clinical needs and their patients’ outcomes. Clinicians are invited to meet our leadership, to ask questions of our product developers and to exchange ideas with their clinician peers. Exactech’s free Academy App helps attendees make the most of their time at the AAOS Annual Meeting with a schedule of surgeon experts’ availability, an overview of Exactech technologies and maps of the Venetian/Sands EXPO exhibit hall. The app can be installed on any mobile device from Exactech’s webpage http://www.exac.com/medical-professionals/academy.

About Exactech

Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, as well as more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech, Inc. can be found at http://www.exac.com. Copies of Exactech’s press releases, SEC filings, current price quotes and other valuable information for investors may be found at http://www.exac.com and http://www.hawkassociates.com.

An investment profile on Exactech may be found at http://www.hawkassociates.com/profile/exac.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert.

This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.

References

1. Data on file at Exactech.

2. Data on file at Exactech.

*Laboratory and/or animal study tests are not necessarily predictive of clinical outcomes.

Contacts

Exactech, Inc.
Investor contacts
Jody Phillips, 352-377-1140
Executive Vice President of Finance & Chief Financial Officer
or
Hawk Associates
Julie Marshall or Frank Hawkins, 305-451-1888
E-mail: EXAC@hawkassociates.com
or
Media contact
Priscilla Bennett, 352-377-1140
Vice President, Corporate & Marketing Communication

Contacts

Exactech, Inc.
Investor contacts
Jody Phillips, 352-377-1140
Executive Vice President of Finance & Chief Financial Officer
or
Hawk Associates
Julie Marshall or Frank Hawkins, 305-451-1888
E-mail: EXAC@hawkassociates.com
or
Media contact
Priscilla Bennett, 352-377-1140
Vice President, Corporate & Marketing Communication